Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey. by Niven, Daniel et al.
  
 University of Groningen
Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators'
survey.
Niven, Daniel; Laupland, Kevin; Tabah, Alexis ; Vesin, Aurelien; Rello, Jordi; Koulenti,






IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2013
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Niven, D., Laupland, K., Tabah, A., Vesin, A., Rello, J., Koulenti, D., ... EUROBACT study group (2013).
Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey.
Critical Care, 17, [R289]. https://doi.org/10.1186/cc13153
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
RESEARCH Open Access
Diagnosis and management of temperature
abnormality in ICUs: a EUROBACT
investigators’ survey
Daniel J Niven1, Kevin B Laupland1,2,3*, Alexis Tabah3,4,5, Aurélien Vesin3, Jordi Rello6,7, Despoina Koulenti8,
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Abstract
Introduction: Although fever and hypothermia are common abnormal physical signs observed in patients
admitted to intensive care units (ICU), little data exist on their optimal management. The objective of this study
was to describe contemporary practices and determinants of management of temperature abnormalities among
patients admitted to ICUs.
Methods: Site leaders of the multi-national EUROBACT study were surveyed regarding diagnosis and management
of temperature abnormalities among patients admitted to their ICUs.
Results: Of the 162 ICUs originally included in EUROBACT, responses were received from 139 (86%) centers in
23 countries in Europe (117), South America (8), Asia (5), North America (4), Australia (3) and Africa (2). A total of
117 (84%) respondents reported use of a specific temperature threshold in their ICU to define fever. A total of 14
different discrete levels were reported with a median of 38.2°C (inter-quartile range, IQR, 38.0°C to 38.5°C). The use
of thermometers was protocolized in 91 (65%) ICUs and a wide range of methods were reportedly used, with
axillary, tympanic and urinary bladder sites as the most common as primary modalities. Only 31 (22%) of
respondents indicated that there was a formal written protocol for temperature control among febrile patients in
their ICUs. In most or all cases practice was to control temperature, to use acetaminophen, and to perform a full
septic workup in febrile patients and that this was usually directed by physician order. While reported practice was
to treat nearly all patients with neurological impairment and most patients with acute coronary syndromes and
infections, severe sepsis and septic shock, this was not the case for most patients with liver failure and fever.
Conclusions: A wide range of definitions and management practices were reported regarding temperature
abnormalities in the critically ill. Documenting temperature abnormality management practices, including variability
in clinical care, is important to inform planning of future studies designed to optimize infection and temperature
management strategies in the critically ill.
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Introduction
Temperature abnormalities occur in approximately 50%
of patients admitted to adult intensive care units (ICUs)
and are associated with increased mortality in select
groups of patients [1-8]. Although strong theoretical
arguments exist both for and against the treatment of
pyrexia, the current literature does not support an out-
come benefit from a particular temperature control
strategy in patients without acute neurological injury
[9-15]. Those against fever control argue that pharmaco-
logic anti-pyresis with non-steroidal anti-inflammatory
drugs and/or acetaminophen is potentially toxic [16,17],
and physical cooling may cause shivering which
increases metabolic demand and patient discomfort. On
the other hand, advocates for fever control argue for
increased patient comfort and a decrease in the risk of
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multi-system organ failure. Hypothermia is associated
with adverse outcome in patients admitted to ICUs and
increases the risk for nosocomial infection [8,18].
A number of small clinical trials have investigated tem-
perature control strategies in febrile critically ill patients
[11-14,19]. Due to the limited guidance provided by these
studies, temperature control in febrile patients remains
inconsistent and further trials are needed. However, in
order to inform the planning of future trials an appraisal
of current attitudes and practices is needed. We therefore
conducted a survey of investigators in the EUROBACT
study [20], a large observational study investigating hospi-
tal acquired bacteremia in ICUs, in order to describe
contemporary temperature treatment practices in an
international context.
Materials and methods
A survey exploring fever management practices was devel-
oped specifically for this study (Additional file 1). Ques-
tions in English surrounding treatment thresholds,
temperature measurement modalities, treatment strategies,
the presence of written treatment protocols, and treatment
of selected patients were included. The survey was pre-
tested by sequential administration to a number of non-
participating unit directors and intensivists and was revised
progressively for clarity. The survey was then administered
to all site leads participating in the EUROBACT study [20]
using a web-based form. Respondents were asked to
answer based on the expected or average practice within
their respective units. Initial non-respondents were sent
email reminders to complete the survey at approximately
two- and four-weeks post-initiation and after were con-
tacted directly to request participation. Data on ICU char-
acteristics were available for all units and was obtained
from the unit-based survey component of the EUROBACT
study. This study involved a voluntary survey of the EURO-
BACT study investigators. The EUROBACT study was
approved by the Institutional Review Board at Paris-Saint
Joseph and each participating center in EUROBACT com-
plied with their local ethical institutional review board
approval standards.
All analyses were conducted using Stata 11.2 (StataCorp,
College Station, TX, USA). Analyses were primarily
descriptive. Non-normally distributed (skewed) continuous
data were reported as medians with interquartile ranges
(IQR) and groups were compared using the Mann-
Whitney test. Grouped categorical data were compared
using the Fisher’s exact test or chi2 for multiple categories.
A P-value less than 0.05 was considered to represent sta-
tistical significance.
Results
Of the 162 ICUs originally included in EUROBACT,
responses were received from 139 (86%) centers in 23
countries in Europe (117), South America (8), Asia (5),
North America (4), Australia (3) and Africa (2). There
were no statistically significant differences among
responders and non-responders with regard to reported
average ICU case-fatality rate, ICU specialty type, uni-
versity-affiliation or public/private ICU. However, non-
respondents had significantly larger ICUs (median 18
beds, IQR, 11 to 25 versus 12 beds, IQR, 9 to 18; P =
0.018) and were more likely to be from non-European
centers (11/33; 33% vs 12/129; 9%; P = 0.001).
Among the 139 respondents, 117 (84%) reported use
of a specific temperature threshold in their ICU to
define fever. A total of 14 different discrete levels were
reported to define fever ranging from 37.0°C to 40.0°C
with a median of 38.2°C (IQR, 38.0°C to 38.5°C). The
use of thermometers was protocolized in 91 (65%) ICUs.
A wide range of temperature measurement methods
were used, with axilla, pulmonary artery catheter, and
rectal thermometry the most commonly reported mod-
alities (Table 1). Axillary, tympanic and urinary bladder
catheter thermometry were reported as the most com-
mon primary means of measurement (Table 1).
When asked about new fever and the ordering of
blood cultures, 83 (60%) reported these were only done
by specific physician order, 25 (18%) stated these were
routinely performed by nurses unless requested other-
wise, 24 (17%) routinely performed these per protocol
based on a predefined temperature threshold, and 7
(5%) indicated use of other approaches. When asked to
report a usual threshold of hypothermia that would trig-
ger the ordering of blood cultures, 129 (93%) responses
were received. Fourteen different discrete levels were
reported which ranged from 34°C to 38.3°C with a med-
ian of 36.0°C (IQR, 35.2°C to 36.0°C). In the event of
hypothermia, 104 (75%) performed cultures only with
specific physician order, 21 (15%) routinely cultured per
protocol based on a specific temperature threshold, 10
(7%) routinely cultured blood as performed by nurses
Table 1 Temperature measurement modalities used in
EUROBACT intensive care units
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unless requested otherwise, and 4 (3%) indicated other
approaches.
When asked specifically about ordering blood cultures
in response to new fever or hypothermia, 136 (98%)
indicated systematic use of aerobic culture bottles, 113
(81%) systematic use of anaerobic bottles, 37 (27%) sys-
tematic use of bottles for fungi, and 42 (30%) indicated
that the type of bottles were specifically defined by phy-
sician order.
In the management of patients, only 31 (22%) respon-
dents indicated that there was a formal written protocol
in place for temperature control among febrile patients in
their ICUs. In most or all cases the practice was to con-
trol temperature, to use acetaminophen and to perform a
septic workup in febrile patients and that this was usually
directed by physician order as shown in Table 2. While
reported practice was to treat nearly all (median score
5 = always) patients with neurological impairment and
most (median score 4 = most) patients with acute coron-
ary syndromes and infections, severe sepsis and
septic shock, this was not the case for many (median
score 3 = sometimes) patients with liver failure as shown
in Table 3. The responses for management (Tables 2
and 3) were similar among European and non-European
respondents with two exceptions. Europeans were more
likely to report either most of the time or always control-
ling fever (99/117; 85% vs 14/22; 64%; P = 0.034) and
were more likely to use acetaminophen for fever control
(82/117; 70% vs. 7/22; 32%; P = 0.001).
An exploratory analysis was conducted by comparing
survey results with clinical variables obtained in the ori-
ginal EUROBACT study. No significant relationships
were found between reported temperature thresholds in
the survey for defining fever and median time to ade-
quate therapy, case-fatality rate or the proportion of
patients with fever in the original study. In addition,
participating ICUs were dichotomized into those that
had case-fatality rates of 30% or less (low) and those
that were greater than 30% (high) for hospital acquired
bloodstream infection requiring ICU admission. No rela-
tionship between any of the survey variables and high or
low case-fatality rate was observed.
Discussion
This study documents major variability in reported prac-
tices in the diagnosis and management of temperature
abnormalities in critically ill patients worldwide. A total
of 14 different discrete thresholds for fever were
reported in this study confirming that there is not wide-
spread accepted levels or consensus for the diagnosis of
fever. Furthermore, the modalities used to measure tem-
perature varied widely across study centers (Table 1).
Although a consensus panel representing the American
College of Critical Care Medicine and the Infectious
Diseases Society of America recommended use of a tem-
perature of 38.3°C or higher to represent fever, the
results of this survey indicate that this definition has not
been widely adopted [3]. Adoption of standard defini-
tions and methods of measurement are needed for stu-
dies defining the determinants and outcomes of
temperature abnormalities in the critically ill.
Although a wide range of temperature measurement
sites and devices were reportedly employed in study
ICUs, it is important to note that these vary in their
accuracy in determining true core temperature. While
pulmonary artery catheters are widely accepted as a gold
standard for temperature measurement in critically ill
patients, the use of this device in ICUs has significantly
decreased in recent years [21]. Relatively few studies
have directly compared other measurement techniques
against this gold standard in ICU patients [22]. Erickson
et al. compared infrared tympanometry, bladder, oral
and axillary temperatures with pulmonary artery ther-
mistor measurements in 38 patients admitted to ICU
Table 2 Management practices for patients with fever admitted to intensive care units
Item Never Rarely Sometimes Most of the time Always *Median (IQR)
Temperature is controlled in febrile patients 0 3 (2%) 23 (17%) 57 (41%) 56 (40%) 4 (4 to 5)
Temperature control in febrile patients is directed
by physician order
3 (2%) 18 (13%) 25 (18%) 54 (39%) 38 (28%) 4 (3 to 5)
Temperature control in febrile patients is directed
by nurses
15 (11%) 41 (30%) 33 (24%) 28 (20%) 21 (15%) 3 (2 to 4)
Acetaminophen (paracetamol) is used to control
temperature in febrile patients
2 (1%) 13 (9%) 35 (25%) 70 (50%) 19 (14%) 4 (3 to 4)
Non-steroidal anti-inflammatory drugs (NSAIDs) are
used to control temperature in febrile patients
36 (26%) 48 (35%) 41 (30%) 13 (9%) 0 2 (1 to 3)
Physical cooling methods are used to control
temperature in febrile patients
1 (1%) 18 (13%) 71 (51%) 36 (26%) 13 (9%) 3 (3 to 4)
New fever triggers a full septic work-up 1 (1%) 6 (4%) 25 (18%) 82 (59%) 25 (18%) 4 (4 to 4)
Empiric antimicrobials are provided to febrile
patients
1 (1%) 24 (17%) 68 (49%) 39 (28%) 7 (5%) 3 (3 to 4)
*Median score (IQR, Interquartile range) of response with 1 = Never, 2 = Rarely, 3 = Sometimes, 4 = Most of the time, and 5 = Always
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[23]. They found generally good average measurement
differences among the different techniques except that
axillary thermometry significantly underestimated true
temperature. In addition, the accuracy of each technique
varied to different extents depending on the levels of
pulmonary artery temperature. Lawson et al. evaluated
temporal artery, tympanic membrane, oral and axillary
thermometers against pulmonary artery catheter tem-
perature among 60 adults with cardiopulmonary disease
admitted to ICU [24]. They found that axillary measure-
ment typically underestimated true temperature, that
oral and temporal artery measurements were the most
accurate, and that tympanic measurements were the
least accurate and precise. Myny et al. evaluated axillary
and temporal artery thermometry as compared to pul-
monary artery catheter in 57 mostly normothermic
adult patients admitted to ICU in Belgium [25]. They
found good agreement between temporal artery thermo-
metry and pulmonary artery catheter but that axillary
thermometry was biased by approximately 0.5 degrees.
In another study conducted in 14 critically ill patients,
Stelfox and colleagues found that while the temporal
artery thermometer had good concordance at normal
temperatures as compared to bladder thermometry, it
was highly inaccurate at extremes of temperatures [26].
While a range of responses was given, most respon-
dents indicated that they treat fever in critically ill
patients most or all of the time (Table 2). Though there
is generally good theoretical and clinical evidence to
support lowering of temperature in febrile patients with
neurological compromise, this is not the case for most
other critically ill patients. Five randomized clinical trials
(RCTs) have been published that have assessed the
effects of anti-pyretic therapy on neurologically intact
febrile patients admitted to ICUs [9,11-14,27]. Four of
these studies found no difference in outcome associated
with temperature lowering therapy but were limited by
small sample size [9,11-13]. On the other hand, Schul-
man et al. compared a strategy of aggressive versus per-
missive fever control in critically ill surgical patients and
found that there was a trend toward increased mortality
associated with fever treatment that necessitated
stopping the trial due to safety concerns [12]. It is also
important to recognize that the effect of fever control
on outcomes may be dependent on whether the fever is
due to an infectious etiology or not [5,6].
Despite the lack of evidence to support treatment of
fever in most patients admitted to ICU, this appears to
be common practice as evidenced by this study and
other reports in the literature. One study from Canada
found that among 100 critically ill adults without acute
neurological injury, 79 received pharmacologic and/or
physical anti-pyretic therapy during an episode of fever
[28]. Similarly, another study conducted in Japan and
Korea found that more than 50% of patients admitted to
ICUs were treated with temperature lowering therapy
[5]. Notably, they found a significantly increased risk for
death associated with non-steroidal anti-inflammatory
drug or acetaminophen therapy in patients with sepsis.
Moreover, an online survey of members of the Austra-
lian and New Zealand Intensive Care Society Clinical
Trials Group found that most respondents reported the
use of interventions to lower temperature among febrile
patients [29].
While this study provides insights into opinions and
practices among a large number of centers, there are
some important limitations that merit discussion. While
EUROBACT does include representation from ICUs
from six continents, most of the participants were Eur-
opean with disproportionate representation from France
and Greece. Centers were not selected randomly from
around the globe and as a result a significant selection
bias is present. It is therefore not possible to accurately
define different regional practices globally. A second
limitation is that we reported responses in this study
directly as entered by respondents without further vali-
dation or auditing of suspect data. As examples, one
respondent reported using a remarkably high tempera-
ture of 40°C or higher to define fever and one reported
that fever never triggered a septic workup (Table 2).
Whether these are truly the cases or whether these are
erroneous responses is not known. A third limitation is
that the responses in this study were reported practices
from one individual from an ICU. These may not be
Table 3 Temperature control practices in selected patient diagnostic subgroups
Item Never Rarely Sometimes Most of the time Always *Median (IQR)
Acute neurological injury (brain or spinal cord) 1 (1%) 3 (2%) 7 (5%) 28 (20%) 100 (72%) 5 (4 to 5)
Septic shock 4 (3%) 8 (6%) 29 (21%) 45 (32%) 53 (38%) 4 (3 to 5)
Severe sepsis without shock 6 (4%) 13 (9%) 28 (20%) 50 (36%) 42 (30%) 4 (3 to 5)
Infection without sepsis 9 (6%) 21 (15%) 32 (23%) 42 (30%) 35 (25%) 4 (3 to 5)
Acute liver failure 9 (6%) 24 (17%) 38 (27%) 38 (27%) 30 (22%) 3 (3 to 4)
Chronic liver failure 11 (8%) 30 (22%) 47 (34%) 31 (22%) 20 (14%) 3 (2 to 4)
Acute coronary syndrome 9 (6%) 12 (9%) 38 (27%) 49 (35%) 31 (22%) 4 (3 to 4)
*Median score (Interquartile range, IQR) of response with 1 = Never, 2 = Rarely, 3 = Sometimes, 4 = Most of the time, and 5 = Always
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reflective of what is actually done in true practice as
would be revealed by a chart audit.
Conclusions
This study documents wide variability in approaches to
diagnosis and management of temperature abnormalities
among critically ill patients. Furthermore, despite being
potentially harmful, most respondents report that they
treat neurologically intact febrile patients admitted to
ICU with temperature lowering interventions. This study
provides support for further efforts to define and imple-
ment best practices for management of temperature
abnormalities in the critically ill.
Key messages
• Temperature abnormalities, including fever and
hypothermia, are common among patients admitted
to ICUs.
• There is major variability among ICUs in the
methods of temperature measurement and for defin-
ing temperature abnormalities.
• Broad practice variation exists among ICUs for the
further investigation and management of patients
with temperature abnormalities.
• Given the commonality, impact on outcome and
wide practice variation in diagnosis and management
of temperature abnormalities in ICUs, further inves-
tigation and consensus are warranted to establish
best practices
Additional material
Additional file 1: EUROBACT Investigators Survey. This survey was
sent to study participants.
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